These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 12351488)

  • 1. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients.
    Salardi S; Zucchini S; Santoni R; Ragni L; Gualandi S; Cicognani A; Cacciari E
    Diabetes Care; 2002 Oct; 25(10):1840-4. PubMed ID: 12351488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects.
    Kaufman FR; Gibson LC; Halvorson M; Carpenter S; Fisher LK; Pitukcheewanont P
    Diabetes Care; 2001 Dec; 24(12):2030-4. PubMed ID: 11723078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes.
    Boland E; Monsod T; Delucia M; Brandt CA; Fernando S; Tamborlane WV
    Diabetes Care; 2001 Nov; 24(11):1858-62. PubMed ID: 11679447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control.
    Chico A; Vidal-Ríos P; Subirà M; Novials A
    Diabetes Care; 2003 Apr; 26(4):1153-7. PubMed ID: 12663589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS).
    Schaepelynck-Bélicar P; Vague P; Simonin G; Lassmann-Vague V
    Diabetes Metab; 2003 Dec; 29(6):608-12. PubMed ID: 14707890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.
    Dungan KM; Buse JB; Largay J; Kelly MM; Button EA; Kato S; Wittlin S
    Diabetes Care; 2006 Jun; 29(6):1214-9. PubMed ID: 16731998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.
    Godbout A; Hammana I; Potvin S; Mainville D; Rakel A; Berthiaume Y; Chiasson JL; Coderre L; Rabasa-Lhoret R
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):568-73. PubMed ID: 18922724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk.
    Schiaffini R; Ciampalini P; Fierabracci A; Spera S; Borrelli P; Bottazzo GF; Crinò A
    Diabetes Metab Res Rev; 2002; 18(4):324-9. PubMed ID: 12203948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
    Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
    Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eight-point glucose testing versus the continuous glucose monitoring system in evaluation of glycemic control in type 1 diabetes.
    Fiallo-Scharer R;
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3387-91. PubMed ID: 15784705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy.
    Heptulla RA; Allen HF; Gross TM; Reiter EO
    Pediatr Diabetes; 2004 Mar; 5(1):10-5. PubMed ID: 15043684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial.
    ; Wilson DM; Xing D; Beck RW; Block J; Bode B; Fox LA; Hirsch I; Kollman C; Laffel L; Ruedy KJ; Steffes M; Tamborlane WV
    Diabetes Care; 2011 Mar; 34(3):540-4. PubMed ID: 21266647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA(1c) in insulin-treated diabetes (MITRE Study).
    Cooke D; Hurel SJ; Casbard A; Steed L; Walker S; Meredith S; Nunn AJ; Manca A; Sculpher M; Barnard M; Kerr D; Weaver JU; Ahlquist J; Newman SP
    Diabet Med; 2009 May; 26(5):540-7. PubMed ID: 19646195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is HbA(1c) affected by glycemic instability?
    Derr R; Garrett E; Stacy GA; Saudek CD
    Diabetes Care; 2003 Oct; 26(10):2728-33. PubMed ID: 14514571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The "glucose pentagon": assessing glycemic control of patients with diabetes mellitus by a model integrating different parameters from glucose profiles.
    Thomas A; Schönauer M; Achermann F; Schnell O; Hanefeld M; Ziegelasch HJ; Mastrototaro J; Heinemann L
    Diabetes Technol Ther; 2009 Jun; 11(6):399-409. PubMed ID: 19459770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial.
    Rohlfing CL; Wiedmeyer HM; Little RR; England JD; Tennill A; Goldstein DE
    Diabetes Care; 2002 Feb; 25(2):275-8. PubMed ID: 11815495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients?
    Kuenen JC; Borg R; Kuik DJ; Zheng H; Schoenfeld D; Diamant M; Nathan DM; Heine RJ;
    Diabetes Care; 2011 Aug; 34(8):1843-7. PubMed ID: 21700921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemoglobin Glycosylation Index is not related with blood glucose.
    Merino-Torres JF; Fajardo-Montañana C; Ferrer-García JC; Piñón-Sellés F
    J Diabetes Complications; 2003; 17(5):249-53. PubMed ID: 12954152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can fructosamine be a surrogate for HbA(1c) in evaluating the achievement of therapeutic goals in diabetes?
    Narbonne H; Renacco E; Pradel V; Portugal H; Vialettes B
    Diabetes Metab; 2001 Nov; 27(5 Pt 1):598-603. PubMed ID: 11694860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemoglobin A(1c) and fructosamine for assessing glycemic control in diabetic patients with CKD stages 3 and 4.
    Chen HS; Wu TE; Lin HD; Jap TS; Hsiao LC; Lee SH; Lin SH
    Am J Kidney Dis; 2010 May; 55(5):867-74. PubMed ID: 20202728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.